U.S. markets open in 8 hours 48 minutes

Bayer Aktiengesellschaft (BAYN.DE)

XETRA - XETRA Precio retrasado. Divisa en EUR.
Añadir a la lista de seguimiento
45.72+0.04 (+0.09%)
Al cierre: 05:36PM CEST

Bayer Aktiengesellschaft

Kaiser-Wilhelm-Allee 1
Leverkusen 51368
49 214 30 1

IndustriaDrug Manufacturers—General
Empleados a tiempo completo102,048

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. Wolfgang U. NicklCFO & Member of Management Board2.12MN/D1969
Mr. Heiko W. J. SchipperMember of Management Board & Pres of the Consumer Health Division1.92MN/D1969
Mr. Stefan OelrichHead of the Pharmaceuticals Division & Member of the Board of Management2.08MN/D1968
Mr. Rodrigo SantosMember of Management Board & Pres of the Crop Science Division2.17MN/D1973
Mr. William N. AndersonChairman of the Management Board & CEON/DN/D1966
Ms. Heike PrinzChief Talent Officer, Labor Director & Member of Management BoardN/DN/D1965
Mr. Bernd-Peter BierHead of Accounting and Head of TaxesN/DN/D1967
Mr. Oliver MaierHead of Investor RelationsN/DN/DN/D
Dr. Gabriel HarnierHead of Law, Patents & ComplianceN/DN/D1971
Mr. Michael PreussHead of Communications, Gov. Relations and Corp. BrandN/DN/DN/D
Los importes son a partir de 31 de diciembre de 2022 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en EUR.


Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases, as well as collaboration with Bicycle Therapeutics to develop bicyclic peptides. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Gestión corporativa

La calificación ISS Governance QuickScore de Bayer Aktiengesellschaft a partir del 1 de septiembre de 2023 es 6. Las puntuaciones principales son Auditoría: 10; Junta: 2; Derechos del accionista: 1; Compensación: 7.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.